Clinical Trial Update: Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating bupivacaine liposome for post-operative shoulder pain management has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Shoulder
• Pain Postoperative
• Shoulder Pain

Drugs mentioned

• Bupivacaine Liposome (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Osteoarthritis of the Shoulder, Shoulder Pain | Phase 4 | Status: WITHDRAWN